Boston Scientific Corp- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Boston Scientific Corp 公司

波士顿科学公司是一家全球医疗器械开发商、制造商和营销商，其产品用于一系列介入医学专业。其 MedSurg 部门包括内窥镜检查、泌尿科和神经调节。其内窥镜业务开发和制造用于诊断和治疗各种胃肠道 (GI) 和肺部疾病的设备，采用微创技术。其泌尿科业务开发和制造用于治疗男性和女性各种泌尿系统疾病的设备。其神经调节业务开发和制造用于治疗各种神经运动障碍和控制慢性疼痛的设备。其心血管部门包括心脏病学和外周介入。其介入心脏病学治疗业务开发和制造用于诊断和治疗冠状动脉疾病和主动脉瓣疾病的技术。该公司还拥有经颈动脉血运重建 (TCAR) 平台。

公司简介

公司代码BSX

公司名称Boston Scientific Corp

上市日期May 19, 1992

成立日期1979

CEOMr. Michael F. (Mike) Mahoney

员工数量53000

证券类型Ordinary Share

年结日May 19

公司地址300 Boston Scientific Way

城市MARLBOROUGH

上市交易所NYSE Consolidated

国家United States of America

邮编01752-1234

电话15086834000

网址https://www.bostonscientific.com/en-US/Home.html

公司代码BSX

上市日期May 19, 1992

成立日期1979

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.87M

-3.05%

Mr. Charles J. Dockendorff, CPA

Independent Director

62.90K

--

Mr. John E. Sununu

Independent Director

52.64K

--

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

41.02K

-10.53%

Ms. Ellen M. Zane

Independent Director

34.94K

--

Mr. David C. Habiger

Independent Director

3.55K

--

Mr. Yoshiaki Fujimori

Independent Director

2.90K

--

Ms. Miriam O' Sullivan

Chief Human Resource Officer, Senior Vice President

--

Mr. Edward J. Ludwig

Lead Independent Director

--

Mr. Scott Olson

Senior Vice President, President - Cardiac Rhythm Management and Diagnostics

--

名称

名称/职务

职务

持股

持股变动

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.87M

-3.05%

Mr. Charles J. Dockendorff, CPA

Independent Director

62.90K

--

Mr. John E. Sununu

Independent Director

52.64K

--

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

41.02K

-10.53%

Ms. Ellen M. Zane

Independent Director

34.94K

--

Mr. David C. Habiger

Independent Director

3.55K

--

收入明细

单位: USD更新时间: 4月2日周三

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Endoscopy

2.69B

16.04%

Interventional Cardiology Therapies

2.65B

15.79%

Peripheral Interventions

2.41B

14.39%

Cardiac Rhythm Management

2.28B

13.61%

Urology

2.20B

13.14%

Other

4.53B

27.03%

地区USD

名称

营收

占比

United States

10.21B

60.97%

EMEA (Europe, Middle East and Africa)

3.23B

19.28%

Asia Pacific

2.69B

16.04%

Latin America and Canada

624.00M

3.73%

业务

地区

业务USD

名称

营收

占比

Endoscopy

2.69B

16.04%

Interventional Cardiology Therapies

2.65B

15.79%

Peripheral Interventions

2.41B

14.39%

Cardiac Rhythm Management

2.28B

13.61%

Urology

2.20B

13.14%

Other

4.53B

27.03%

股东统计

更新时间: 2月21日周五

持股股东

股东类型

持股股东

股东统计

占比

The Vanguard Group, Inc.

8.94%

Fidelity Management & Research Company LLC

8.19%

BlackRock Institutional Trust Company, N.A.

5.19%

State Street Global Advisors (US)

4.32%

PRIMECAP Management Company

2.50%

Other

70.86%

持股股东

股东统计

占比

The Vanguard Group, Inc.

8.94%

Fidelity Management & Research Company LLC

8.19%

BlackRock Institutional Trust Company, N.A.

5.19%

State Street Global Advisors (US)

4.32%

PRIMECAP Management Company

2.50%

Other

70.86%

股东类型

股东统计

占比

Investment Advisor

43.30%

Investment Advisor/Hedge Fund

37.30%

Hedge Fund

3.29%

Pension Fund

2.97%

Research Firm

2.45%

Bank and Trust

1.64%

Sovereign Wealth Fund

1.47%

Private Equity

0.21%

Insurance Company

0.21%

Other

7.16%

机构持股

更新时间: 1月19日周日

报告期

机构数

持股数

持股占比

持股变动

2025Q1

2535

1.38B

93.49%

+4.22M

2024Q4

2559

1.38B

93.61%

+1.09M

2024Q3

2417

1.37B

92.76%

-24.32M

2024Q2

2341

1.37B

93.29%

-18.17M

2024Q1

2227

1.37B

93.23%

-40.14M

2023Q4

2171

1.39B

94.95%

-25.34M

2023Q3

2110

1.39B

95.17%

-6.29M

2023Q2

2081

1.38B

95.67%

-15.63M

2023Q1

2012

1.36B

94.85%

-23.81M

2022Q4

1993

1.36B

94.66%

-54.91M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

The Vanguard Group, Inc.

132.25M

8.94%

+1.62M

+1.24%

Dec 31, 2024

Fidelity Management & Research Company LLC

121.20M

8.19%

-2.05M

-1.66%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

76.72M

5.19%

+7.50M

+10.84%

Dec 31, 2024

State Street Global Advisors (US)

63.96M

4.32%

+1.12M

+1.78%

Dec 31, 2024

PRIMECAP Management Company

36.93M

2.5%

-896.83K

-2.37%

Dec 31, 2024

Wellington Management Company, LLP

36.17M

2.45%

+3.34M

+10.19%

Dec 31, 2024

Geode Capital Management, L.L.C.

30.63M

2.07%

+1.04M

+3.52%

Dec 31, 2024

Capital World Investors

27.90M

1.89%

+6.22M

+28.67%

Dec 31, 2024

The Bollard Group, LLC

20.73M

1.4%

-510.32K

-2.40%

Dec 31, 2024

BlackRock Investment Management (UK) Ltd.

20.37M

1.38%

+757.90K

+3.86%

Dec 31, 2024

持股ETF

更新时间: 4月2日周三

机构名称

占比

iShares U.S. Medical Devices ETF

12.01%

Goldman Sachs Future Health Care Equity ETF

8.56%

NYLI Healthy Hearts ETF

5.62%

iShares Health Innovation Active ETF

5.12%

JPMorgan Healthcare Leaders ETF

4.25%

Global X Aging Population ETF

4.17%

Hennessy Stance ESG ETF

3.4%

FT Raymond James Multicap Growth Equity ETF

2.84%

Tema Cardiovascular and Metabolic ETF

2.83%

Health Care Select Sector SPDR Fund

2.82%

iShares U.S. Medical Devices ETF

占比12.01%

Goldman Sachs Future Health Care Equity ETF

占比8.56%

NYLI Healthy Hearts ETF

占比5.62%

iShares Health Innovation Active ETF

占比5.12%

JPMorgan Healthcare Leaders ETF

占比4.25%

Global X Aging Population ETF

占比4.17%

Hennessy Stance ESG ETF

占比3.4%

FT Raymond James Multicap Growth Equity ETF

占比2.84%

Tema Cardiovascular and Metabolic ETF

占比2.83%

Health Care Select Sector SPDR Fund

占比2.82%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Boston Scientific Corp

89.700USD

Boston Scientific Corp

89.700

概览

公司